[go: up one dir, main page]

IL109547A - 3-(Tricyclic indolyl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione derivatives their preparation and pharmaceutical compositions containing them - Google Patents

3-(Tricyclic indolyl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL109547A
IL109547A IL10954794A IL10954794A IL109547A IL 109547 A IL109547 A IL 109547A IL 10954794 A IL10954794 A IL 10954794A IL 10954794 A IL10954794 A IL 10954794A IL 109547 A IL109547 A IL 109547A
Authority
IL
Israel
Prior art keywords
indol
methyl
indolyl
pyrrole
dione
Prior art date
Application number
IL10954794A
Other languages
English (en)
Other versions
IL109547A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939309602A external-priority patent/GB9309602D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL109547A0 publication Critical patent/IL109547A0/xx
Publication of IL109547A publication Critical patent/IL109547A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
IL10954794A 1993-05-10 1994-05-04 3-(Tricyclic indolyl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione derivatives their preparation and pharmaceutical compositions containing them IL109547A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309602A GB9309602D0 (en) 1993-05-10 1993-05-10 Substituted pyrroles
GB9403249A GB9403249D0 (en) 1993-05-10 1994-02-21 Substituted pyrroles

Publications (2)

Publication Number Publication Date
IL109547A0 IL109547A0 (en) 1994-08-26
IL109547A true IL109547A (en) 1998-07-15

Family

ID=26302877

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10954794A IL109547A (en) 1993-05-10 1994-05-04 3-(Tricyclic indolyl)-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione derivatives their preparation and pharmaceutical compositions containing them

Country Status (25)

Country Link
EP (1) EP0624586B1 (zh)
JP (1) JP2668818B2 (zh)
CN (1) CN1048014C (zh)
AT (1) ATE184007T1 (zh)
AU (1) AU678435B2 (zh)
BG (1) BG98761A (zh)
BR (1) BR9401935A (zh)
CA (1) CA2121567A1 (zh)
CZ (1) CZ112894A3 (zh)
DE (1) DE69420310T2 (zh)
DK (1) DK0624586T3 (zh)
ES (1) ES2137281T3 (zh)
FI (1) FI106961B (zh)
GR (1) GR3031901T3 (zh)
HR (1) HRP940287B1 (zh)
HU (1) HU215954B (zh)
IL (1) IL109547A (zh)
IS (1) IS1690B (zh)
LT (1) LT3288B (zh)
LV (1) LV11173B (zh)
NO (1) NO301230B1 (zh)
NZ (1) NZ260475A (zh)
RU (1) RU2141960C1 (zh)
SI (1) SI0624586T1 (zh)
SK (1) SK53594A3 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA44690C2 (uk) * 1993-12-07 2002-03-15 Елі Ліллі Енд Компані Макроциклічна сполука іміду біс-індол-малеїнової кислоти, спосіб її одержання та фармацевтична композиція, макроциклічні сполуки іміду біс-індол-малеїнової кислоти та біс-індол-малеїнового ангідриду, спосіб одержання (варіанти)
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
AU1339895A (en) * 1993-12-23 1995-07-10 Eli Lilly And Company Protein kinase c inhibitors
EP0695755B1 (en) * 1994-08-04 1998-10-21 F. Hoffmann-La Roche AG Pyrrolocarbazole
CA2249205A1 (en) * 1996-03-20 1997-09-25 Eli Lilly And Company Synthesis of indolylmaleimides
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
PL366701A1 (en) 2000-07-27 2005-02-07 F.Hoffmann-La Roche Ag 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
HU230798B1 (hu) 2001-10-30 2018-06-28 Novartis Ag Staurosporin-származékok mint az FLT3 receptor tirozin-kináz aktivitás inhibitorai
CA2393720C (en) 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
EP1653973A1 (en) 2003-08-08 2006-05-10 Novartis AG Combinations comprising staurosporines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
CZ280738B6 (cs) * 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
DE3833008A1 (de) * 1988-09-29 1990-04-05 Goedecke Ag Pyrrolocarbozol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles

Also Published As

Publication number Publication date
AU678435B2 (en) 1997-05-29
JP2668818B2 (ja) 1997-10-27
DE69420310D1 (de) 1999-10-07
IL109547A0 (en) 1994-08-26
FI942158A0 (fi) 1994-05-10
HRP940287A2 (en) 1996-12-31
CZ112894A3 (en) 1994-12-15
BR9401935A (pt) 1995-03-07
GR3031901T3 (en) 2000-02-29
LV11173A (lv) 1996-04-20
EP0624586A1 (en) 1994-11-17
NO941682D0 (no) 1994-05-06
FI942158A7 (fi) 1994-11-11
LV11173B (en) 1996-06-20
FI106961B (fi) 2001-05-15
CA2121567A1 (en) 1994-11-11
AU6055594A (en) 1994-11-17
LTIP1927A (en) 1994-11-25
EP0624586B1 (en) 1999-09-01
CN1048014C (zh) 2000-01-05
NZ260475A (en) 1996-02-27
NO941682L (no) 1994-11-11
DK0624586T3 (da) 2000-03-27
HU9401298D0 (en) 1994-08-29
ES2137281T3 (es) 1999-12-16
LT3288B (en) 1995-06-26
HUT71492A (en) 1995-11-28
RU2141960C1 (ru) 1999-11-27
HRP940287B1 (en) 2000-02-29
DE69420310T2 (de) 2000-04-13
CN1103402A (zh) 1995-06-07
IS4162A (is) 1994-11-11
IS1690B (is) 1998-04-20
HU215954B (hu) 1999-03-29
NO301230B1 (no) 1997-09-29
SI0624586T1 (en) 1999-12-31
SK53594A3 (en) 1995-02-08
ATE184007T1 (de) 1999-09-15
JPH06329672A (ja) 1994-11-29
BG98761A (en) 1995-03-31

Similar Documents

Publication Publication Date Title
RU2075474C1 (ru) Замещенные пирролы, а также их фармацевтически приемлемые кислотноаддитивные соли, способ их получения и фармацевтическая композиция
US5292747A (en) Substituted pyrroles
CA2010636C (en) Substituted pyrroles
RU2114620C1 (ru) Ингибитор атеросклеротического утолщения внутренней оболочки сосудов
EP0624586B1 (en) Substituted pyrroles
KR0173450B1 (ko) 치환된 피롤, 이의 제조방법 및 이를 함유하는 의약품
WO2007097981A2 (en) Alpha carbolines and uses thereof
HU190984B (en) Process for producing new furo-, thieno- or pinolo-azepin derivatives
US5721230A (en) Substituted pyrroles
EP0338989B1 (en) Heterotetracyclic lactam derivatives, process for their preparation, and pharmaceutical compositions containing them
EP0347980A1 (en) 8,9-Annelated beta-carbolines and 8,9-anelated-3,4-dihydro-beta-carbolines
KR100331515B1 (ko) 치환된피롤
HU207318B (en) Process for producing lactame derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees